Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.
about
Emerging use of combination therapies for the management of type 2 diabetes - focus on saxagliptin and dapagliflozin.Dapagliflozin slows the progression of the renal and liver fibrosis associated with type 2 diabetes.SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial.The effect of dapagliflozin treatment on epicardial adipose tissue volume.SGLT2 inhibitors: are they safe?Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance.Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis.Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease
P2860
Q38645792-31380D3B-07D8-4C30-9D43-2AA3631F0F1CQ46320593-4B575988-196B-448C-8491-62462C402618Q47095186-9EE8FBBC-360B-4CDC-8703-47DC6C60C696Q47142556-FCCC0473-159D-48B9-8596-4278B9FC89F1Q47642298-89AEF2F4-1199-4674-A564-77E24E484F6CQ48199667-27C0262C-CFFB-45B8-82C9-6A4C044E490DQ48544976-73AEC17A-6EC1-43EF-954A-01D08A1637BEQ51245398-F1A8DCF0-8E63-417D-AD4F-BCF68D57A6B2Q58724925-BA4BDFF9-9EF1-4D68-A21B-CD0D71BD933A
P2860
Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dapagliflozin decreases small ...... : comparison with sitagliptin.
@en
Dapagliflozin decreases small ...... : comparison with sitagliptin.
@nl
type
label
Dapagliflozin decreases small ...... : comparison with sitagliptin.
@en
Dapagliflozin decreases small ...... : comparison with sitagliptin.
@nl
prefLabel
Dapagliflozin decreases small ...... : comparison with sitagliptin.
@en
Dapagliflozin decreases small ...... : comparison with sitagliptin.
@nl
P2093
P2860
P1476
Dapagliflozin decreases small ...... : comparison with sitagliptin.
@en
P2093
Anna Osamura
Makoto Ohara
Masako Tomoyasu
Noriko Nakanishi
Saki Yamamoto
Takeshi Yamamoto
Tomoyasu Fukui
Toshiyuki Hayashi
Tsutomu Hirano
Yasuki Ito
P2860
P2888
P356
10.1186/S12933-016-0491-5
P407
P577
2017-01-13T00:00:00Z
P6179
1036105132